| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.27B | — | -10.5% |
| Cost of Revenue | $1.75B | — | -2.8% |
| Gross Profit | $510.0M | — | -29.7% |
| R&D Expense | $37.0M | — | +5.7% |
| SG&A Expense | $258.0M | — | -1.1% |
| Operating Income | $120.0M | — | -70.5% |
| Interest Expense | $66.0M | — | +203.1% |
| Pre-tax Income | $54.0M | — | -84.3% |
| Income Tax | $15.0M | — | -83.0% |
| Net Income | -$105.0M | — | -12.9% |
| EPS (Basic) | -$1.30 | — | -20.4% |
| EPS (Diluted) | -$1.29 | — | -19.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $272.0M | -21.2% | -32.0% |
| Accounts Receivable | $1.35B | +44.4% | -13.1% |
| Inventory | $1.49B | +1.4% | +6.0% |
| Current Assets | $3.72B | +11.3% | -5.1% |
| Total Assets | $13.09B | +0.9% | -8.2% |
| Current Liabilities | $3.01B | +13.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$154.0M | — | -214.3% |
| Investing Cash Flow | -$190.0M | — | -19.5% |
| Financing Cash Flow | $235.0M | — | -11.0% |
| +10.7% |
| Long-term Debt | $5.12B | +0.0% | +1.6% |
| Total Liabilities | $9.41B | +3.5% | +0.7% |
| Stockholders' Equity | $3.64B | -5.4% | -25.4% |